Search alternatives:
largest decrease » largest decreases (Expand Search), marked decrease (Expand Search)
linear decrease » linear increase (Expand Search)
larger decrease » marked decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
largest decrease » largest decreases (Expand Search), marked decrease (Expand Search)
linear decrease » linear increase (Expand Search)
larger decrease » marked decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
51601
-
51602
-
51603
Deciphering Nonbioavailable Substructures Improves the Bioavailability of Antidepressants by Serotonin Transporter
Published 2023“…A more potent SERT inhibitor <b>DH4</b> was discovered with a bioavailability of 83.28% in rats by replacing the nonbioavailable substructure of approved drug vilazodone. …”
-
51604
Deciphering Nonbioavailable Substructures Improves the Bioavailability of Antidepressants by Serotonin Transporter
Published 2023“…A more potent SERT inhibitor <b>DH4</b> was discovered with a bioavailability of 83.28% in rats by replacing the nonbioavailable substructure of approved drug vilazodone. …”
-
51605
Deciphering Nonbioavailable Substructures Improves the Bioavailability of Antidepressants by Serotonin Transporter
Published 2023“…A more potent SERT inhibitor <b>DH4</b> was discovered with a bioavailability of 83.28% in rats by replacing the nonbioavailable substructure of approved drug vilazodone. …”
-
51606
Deciphering Nonbioavailable Substructures Improves the Bioavailability of Antidepressants by Serotonin Transporter
Published 2023“…A more potent SERT inhibitor <b>DH4</b> was discovered with a bioavailability of 83.28% in rats by replacing the nonbioavailable substructure of approved drug vilazodone. …”
-
51607
Deciphering Nonbioavailable Substructures Improves the Bioavailability of Antidepressants by Serotonin Transporter
Published 2023“…A more potent SERT inhibitor <b>DH4</b> was discovered with a bioavailability of 83.28% in rats by replacing the nonbioavailable substructure of approved drug vilazodone. …”
-
51608
-
51609
-
51610
-
51611
-
51612
-
51613
-
51614
-
51615
-
51616
-
51617
-
51618
-
51619
Rapidly Thermoreversible and Biodegradable Polypeptide Hydrogels with Sol–Gel–Sol Transition Dependent on Subtle Manipulation of Side Groups
Published 2021“…Intriguingly, the obtained hydrogels can transform from gel to sol within 10–70 s in response to the temperature decrease from 37 to 0 °C. The thermosensitive sol–gel–sol transitions are markedly faster than previously reported thermoreversible PEG-poly(l-glutamate) derivative hydrogels with subtle differences in the side groups and a widely studied poly(d,l-lactide-<i>co</i>-glycolide)-<i>b</i>-PEG-<i>b</i>-poly(d,l-lactide-<i>co</i>-glycolide) (PLGA-PEG-PLGA) hydrogel that required a much longer time of 40∼150 min. …”
-
51620
Rapidly Thermoreversible and Biodegradable Polypeptide Hydrogels with Sol–Gel–Sol Transition Dependent on Subtle Manipulation of Side Groups
Published 2021“…Intriguingly, the obtained hydrogels can transform from gel to sol within 10–70 s in response to the temperature decrease from 37 to 0 °C. The thermosensitive sol–gel–sol transitions are markedly faster than previously reported thermoreversible PEG-poly(l-glutamate) derivative hydrogels with subtle differences in the side groups and a widely studied poly(d,l-lactide-<i>co</i>-glycolide)-<i>b</i>-PEG-<i>b</i>-poly(d,l-lactide-<i>co</i>-glycolide) (PLGA-PEG-PLGA) hydrogel that required a much longer time of 40∼150 min. …”